Upregulation of GLT1 expression influences glutamatergic input to the amygdala of the nucleus ambiguous (NAc), which may result in depression-like behaviours prompted by opioid withdrawal [42]. This evidence concerns the gene SLC1A2 and depressive symptom measurement.